Pinal-Fernandez I, Selva-O' Callaghan A, Grau JM. Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev 2014;13(4-5):379-82. https://doi.org/10.1016/j.autrev.2014.01.019.

Ihn H. Eosinophilic fasciitis: From pathophysiology to treatment. Allergol Int 2019;68(4):437-9. https://doi.org/10.1016/j.alit.2019.03.001

Dang QM, Watanabe R, Shiomi M, Fukumoto K, Nobashi TW, Okano T, et al. Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update. Int J Mol Sci 2023;24(6):5643. https://doi.org/10.3390/ijms24065643

Cappelli LC, Gutierrez AK, Bingham CO, Shah AA. Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature. Arthritis Care Res 2017;69(11):1751-63. https://doi.org/10.1002/acr.23177

Amrane K, Le Meur C, Thuillier P, Alemany P, Niel C, Renault D, et al. Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT. Front Med 2022;20(9)1078560. https://doi.org/10.3389/fmed.2022.1078560

Chan KK, Magro C, Shoushtari A, Rudin C, Rotemberg V, Rossi A, et al. Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature. Oncologist 2020;25(2):140-9. https://doi.org/10.1634/theoncologist.2019-0508

Parker MJS, Roberts ME, Lorigan PC, Du Plessis DG, Chinoy H. Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab. BMJ Case Rep 2018; 2018: bcr2017223249. https://doi.org/10.1136/bcr-2017-223249

Mazori DR, Femia AN, Vleugels RA. Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment. Curr Rheumatol Rep 2017;19(12):74. https://doi.org/10.1007/s11926-017-0700-6

Bourcier L, St-Hilaire È, LeBlanc M, Picard L. Complete reversibility of pembrolizumab-induced eosinophilic fasciitis without corticosteroids: A case report. SAGE Open Med Case Rep 2021;9:2050313X211025111. https://doi.org/10.1177/2050313x211025111

Samborski W, Eaba R. AB0217 Intravenous pulse corticosteroid therapy in patient with eosinophilic fasciitis. Ann Rheum Dis 2001;60(Suppl 1):A290.2. https://doi.org/10.1136/annrheumdis-2001.738